4.8 Article

Lower iodine storage in the placenta is associated with gestational diabetes mellitus

Journal

BMC MEDICINE
Volume 19, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12916-021-01919-4

Keywords

Neonates; Placenta; Iodine; ICP-MS; Gestational diabetes mellitus; Pregnancy; DOHaD

Funding

  1. European Research Council [310898, 282413]
  2. Flemish Scientific Fund (FWO) [G073315N]
  3. FWO [12Q0517N, 12D7718N]
  4. European Research Council (ERC) [282413, 310898] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

The study found that higher placental iodine concentrations are associated with a lower risk of GDM, and lower placental iodine load is linked with altered plasma insulin concentration, HOMA-IR index, and beta-cell activity. These findings suggest that mild-to-moderate iodine deficiency may be associated with subclinical and early-onset changes in normal insulin homeostasis in healthy pregnant women, indicating a need for further research on the functional link between gestational iodine status and GDM.
Background: The micronutrient iodine is essential for a healthy intrauterine environment and is required for optimal fetal growth and neurodevelopment. Evidence linking urinary iodine concentrations, which mainly reflects short-term iodine intake, to gestational diabetes mellitus (GDM) is inconclusive. Although the placental concentrations would better reflect the long-term gestational iodine status, no studies to date have investigated the association between the placental iodine load and the risk at GDM. Moreover, evidence is lacking whether placental iodine could play a role in biomarkers of insulin resistance and beta-cell activity. Methods: We assessed the incidence of GDM between weeks 24 and 28 of gestation for 471 mother-neonate pairs from the ENVIRONAGE birth cohort. In placentas, we determined the iodine concentrations. In maternal and cord blood, we measured the insulin concentrations, the Homeostasis Model Assessment (HOMA) for insulin resistance (IR) index, and beta-cell activity. Logistic regression was used to estimate the odds ratios (OR) of GDM, and the population attributable factor (PAF) was calculated. Generalized linear models estimated the changes in insulin, HOMA-IR, and beta-cell activity for a 5 mu g/kg increase in placental iodine. Results: Higher placental iodine concentrations decreased the risk at GDM (OR=0.82; 95%CI 0.72 to 0.93; p=0.003). According to the PAF, 54.2% (95%CI 11.4 to 82.3%; p=0.0006) of the GDM cases could be prevented if the mothers of the lowest tertile of placental iodine would have placental iodine levels as those belonging to the highest tertile. In cord blood, the plasma insulin concentration was inversely associated with the placental iodine load (beta = -4.8%; 95%CI -8.9 to -0.6%; p=0.026). Conclusions: Higher concentrations of placental iodine are linked with a lower incidence of GDM. Moreover, a lower placental iodine load is associated with an altered plasma insulin concentration, HOMA-IR index, and beta-cell activity. These findings postulate that a mild-to-moderate iodine deficiency could be linked with subclinical and early-onset alterations in the normal insulin homeostasis in healthy pregnant women. Nevertheless, the functional link between gestational iodine status and GDM warrants further research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available